Orion OYJ Unsponsored ADR (OTCMKTS:ORINY - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Friday . The company traded as high as $37.53 and last traded at $37.53, with a volume of 136 shares traded. The stock had previously closed at $35.45.
Orion OYJ Stock Performance
The stock has a market cap of $10.59 billion, a PE ratio of 28.65 and a beta of 0.07. The company has a quick ratio of 2.27, a current ratio of 3.79 and a debt-to-equity ratio of 0.27. The stock has a 50-day moving average of $32.22 and a 200 day moving average of $28.30.
Orion OYJ (OTCMKTS:ORINY - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $0.23 EPS for the quarter. Orion OYJ had a return on equity of 36.23% and a net margin of 21.74%. The firm had revenue of $373.03 million for the quarter. Equities analysts predict that Orion OYJ Unsponsored ADR will post 1.18 EPS for the current fiscal year.
About Orion OYJ
(
Get Free Report)
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Further Reading
Before you consider Orion OYJ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orion OYJ wasn't on the list.
While Orion OYJ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
